Cases 31 - 40 of 48
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al
as 1:2020cv00318
Plaintiff:
Vanda Pharmaceuticals Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al
as 1:2020cv00235
Plaintiff:
Vanda Pharmaceuticals Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
Amgen Inc. et al v. MSN Pharmaceuticals, Inc. et al
as 1:2020cv00137
Defendant:
MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited
Plaintiff:
Amgen Inc. and Les Laboratoires Servier
Cause Of Action: 35 U.S.C. § 1
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2019cv02017
Plaintiff:
Exelixis, Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al
as 1:2019cv00926
Plaintiff:
Vanda Pharmaceuticals Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. MSN Laboratories Private Limited et al
as 1:2019cv00205
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
H. Lundbeck A/S et al v. MSN Laboratories Private Limited et al
as 1:2018cv00853
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
MSN Laboratories Private Limited , MSN Pharmaceuticals, Inc. and MSN Pharmachem Private Limited
Counter_claimant:
MSN Pharmachem Private Limited , MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited
Counter_defendant:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals America, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
